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Abstract: A monoclonal antibody specific to ochratoxin B (OTB) was employed for the 
development of an indirect competitive OTB-ELISA. The optimized OTB-ELISA resulted 
in a limit of detection (LOD) for OTB of 3 µ g/L (8 nM), a limit of quantification (LOQ) of 
3.7 µ g/L (10 nM), and a 50% inhibitory concentration (IC50) of 150 nM. Due to very low 
cross-reactivity to OTA (2.7%) and structurally related molecules (0%), this OTB-ELISA 
was found to be suitable to detect OTB with excellent precision in different matrices, i.e., 
beer, coffee and wine. Therefore, this OTB-ELISA will allow screening of OTB in food 
and feed products. 
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1. Introduction 
Ochratoxins  are  known  contaminants  of  human  food  and  animal  feed,  frequently  detected  for 
example in cereals, coffee, beer and wine [1]. Ochratoxin B (OTB) is the non-chlorinated analog of the 
naturally mycotoxin ochratoxin A (OTA, Figure 1). Both are secondary metabolites of Aspergillus and 
Penicillium  species  [1],  and  OTB  is  therefore  frequently  found  in  mold-contaminated  products 
containing OTA, albeit at lower concentrations than OTA [2]. Indeed, a OTB/OTA biosynthesis ratio 
of approximately 1:5 is reported for Aspergillus ochraceus as well as various Penicillium species [3] 
that produce OTA and OTB concentrations in the high ppb range [4].  
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Figure 1. Chemical structures of ochratoxin A and B. Ochratoxin A, R1 = Cl; ochratoxin B, R1 = H. 
 
The  toxicity  of  OTA  has  been  intensively  studied  (for  review  see  [1,5–7])  and  some  of  the 
mechanisms of acute toxicity of OTA are well described [1]. More recently, an epigenetic mode of 
action underlying chronic OTA toxicity and carcinogenicity in rodents was proposed [5]. Despite the 
profound species- and sex differences in susceptibility to OTA observed [1] and the known problems 
in extrapolating human risk and predicting disease from animal data [8], OTA was classified by the 
IARC as a possible human carcinogen (group 2B) [9]. The latter was based on the available in vitro 
data, in vivo animal studies, the human epidemiologic data from the Balkans, and the broad human 
exposure to OTA, thereby also mandating routine determination of OTA contamination levels in food 
and animal feed.  
OTB has generally been considered less toxic. However, recent in vitro studies have shown that 
OTB effects are strongly dependent on the model chosen [10–12]. Moreover, experimental evidence 
suggested that OTB has a different mode of action than OTA. Recently, it has been shown in LLC-PK1 
cells that the cytotoxic effects of OTB were not reversible upon toxin removal, whereas they were 
reversible with OTA [12]. Similarly, Mally et al. [10] demonstrated that the cytotoxic concentrations 
and effects of OTA and OTB in LLC-PK1 cells were comparable. Contrary to OTA, where extreme 
concentrations in vitro were reported to induce micronuclei and DNA migration in the single-cell gel 
electrophoresis assay, thus suggesting genotoxicity of OTA, OTB had no such effects but rather caused 
pronounced inhibition of cell division already at much lower concentrations [13]. From the above data, 
it  may  be  concluded  that  OTA  and  OTB  have  a  similar potential to  induce cytotoxicity  in  vitro, 
however large differences are apparent with respect to their potential to induce nephrotoxicity in rats 
[10]. Indeed, the biotransformation and elimination of OTB appeared more extensive than OTA in rats 
[10]. Moreover, although OTA is considered to be the major causative factor in Mycotoxic Porcine 
Nephropathy (MPN) in many European countries [14,15], the role of OTA in a similar human disease 
(BEN,  Balkan  Endemic  Nephropathy)  and  in  the  observed  increased  incidence  of  human  renal 
urothelial tumors is still under debate [16–18]. The potential role of OTB in both the human and the 
porcine nephropathy and the human urothelial tumors, has so far largely been ignored and remains to 
be elucidated. 
Based on the above findings, it can be assumed that OTB may pose a risk to humans. Thus, OTB is 
at least as important as OTA and it may be concluded that routine detection of OTB and OTA in food 
and beverages would be a prerequisite for improved determination of ochratoxin risk. Indeed, in order 
to protect consumers from mycotoxin-related risks, the European Union (EU) has defined regulatory Toxins 2010, 2                             
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limits for OTA, i.e., 10 ppb in dried vine fruits and instant coffee, 5 ppb in cereals and roasted coffee 
and 2 ppb in wine [19], but has no regulatory limits for OTB.  
Employing high-performance liquid chromatography (HPLC) and liquid chromatography coupled 
with  tandem  mass  spectrometry  (LC/MS/MS),  with  a  limit  of  quantification  (LOQ)  of  0.1  µ g/kg 
sample, a recent study demonstrated the co-occurrence of OTA and OTB in commercial foods in Japan 
[20]. OTA was detectable in 44 of 157 samples, whereas OTB was found in fruit and cacao products 
containing relatively high levels of OTA. In a similar study [21], OTA and OTB were detected in 143 
(21%) and 68 (10%), respectively, in a total of 681 samples. The latter emphasizes that OTB is a 
contaminant to be seriously considered in the determination of ochratoxin risk. However, although 
many laboratories already routinely employ HPLC and LC MS/MS technology, more rapid and less 
cost  intensive  methodology  would  be  key  to  a  broader,  routine  and  more  frequent  analysis  of 
ochratoxin B contaminated food and feed. 
For above purpose a monoclonal anti-OTB antibody was produced and initially characterized in an 
earlier study [22]. The overall aim of the current study was to purify and characterize the antibody and 
to establish and optimize an indirect competitive OTB-ELISA suitable for the high-throughput robust 
detection of OTB in different food matrices, albeit with the slightly higher LOQ than is typical for 
HPLC and LC MS/MS technology. 
2. Materials and Methods 
2.1. Materials 
Stock solutions (1 mM) of OTA and OTB (Sigma-Aldrich) were prepared in PBS and stored in 
small aliquots at −20 ° C. 
The  OTA-BSA  was  obtained  from  Sigma-Aldrich,  whereas  the  OTB-BSA  conjugate  was 
synthesized in our laboratory as earlier described [22]. Blocking reagents were purchased from Fluka 
(Skim milk powder, #70166), Sigma-Aldrich (Ovalbumin, #A5503; Casein, #009000719) and from 
Roth (BSA, #8076.2). Goat anti-mouse IgG (Fc-Fragment)-HRP (Dianova, #115-035-008) and rabbit 
anti-mouse IgG-HRP (Sigma, #A9044) were used for ELISA and Western blotting, respectively. ECL 
(GE  Healthcare,  #RPN2132)  and  TMB  liquid  substrate  (Sigma-Aldrich,  #T4444)  were  used  as 
substrates. Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich, Germany, and 
were of highest purity available. 
2.2. Production of the OTB Antibody 
The monoclonal mouse anti-OTB antibody (OTB mab), IgG1 with -chain, was produced using the 
hybridoma technique. The production and preliminary characterization of this OTB mab was recently 
described in detail by Heussner et al. [22]. 
2.3. Purification and Characterization of the OTB Antibody  
For purification, the supernatants from the stable hybridoma cell line 2F1.E10 [22] were collected 
and stored at −20 ° C. Purification was performed using protein G sepharose affinity chromatography 
according to manufacturer's recommendations (HiTrap, GE Healthcare). Briefly, samples were diluted Toxins 2010, 2                             
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with binding buffer (20 mM NaH2PO4, pH 7.0) and applied to the column. After washing, elution was 
achieved with Glycin-HCl (100 mM, pH 2.7). To avoid globulin damage, pH was titrated to neutral 
immediately with Tris-HCl (1 M, pH 9.0).  
Eluted  fractions  were  collected  and  protein  content  was  determined  via  the  Bradford  assay 
calibrated  with  bovine  -globulin  according  to  manufacturer’s  instructions  (Roti®-Quant,  Roth, 
Germany). Additionally, the purity of the protein-containing fractions was assayed via SDS-PAGE 
under  reducing  and  non-reducing  conditions  on  12%  and  7.5%  polyacrylamide  gels,  respectively. 
Proteins were stained with silver nitrate [23]. 
Antibody-containing  fractions  were  pooled  and  calculated  protein  content  was  confirmed  via 
Bradford determination. Purified pooled OTB mab was diluted with glycerol (final concentration of 
glycerol 50% v/v) and stored in small aliquots at −20 ° C. 
2.4. Characterization of Ochratoxin-BSA Conjugates  
Two  different  ochratoxin-BSA  conjugates  were  used:  OTB-BSA  (own  synthesis,  [22])  and  
OTA-BSA (Sigma-Aldrich). For both, the stability was unknown and confirmation of protein and 
ochratoxin content were prerequisites for further use in the Western blot analyses (see below).  
Protein concentration was determined via the Bradford micro assay according to the manufacturer’s 
recommendations (Roti®-Quant, Roth, Germany) using non-linear calibration with BSA. Ochratoxin 
concentrations were determined by photometric analysis at 360 nm and 380 nm for OTB and OTA, 
respectively, using non-linear calibration with ochratoxins in Tris buffer. As determination of low 
ochratoxin concentrations was the ultimate goal, the data were confirmed by additional readings using 
increasing ochratoxin sample spiking levels (1, 10 and 100 µ M). 
2.5. Detection and Quantification of Ochratoxin-BSA Conjugates via Western Blot Analysis  
For  semi-quantitative  detection,  ochratoxin-BSA  conjugates  were  boiled  in  SDS-PAGE  sample 
buffer  (187.5  mM  Tris-HCl,  pH  8.8,  10%  Glycerol,  2%  SDS,  20%  2-Mercaptoethanol,  1% 
Bromophenol  blue)  and  separated  on  a  10%  polyacrylamide  gel.  Proteins  were  blotted  onto  a 
nitrocellulose membrane (0.2 µ m pore size, Roth, Germany), reversibly stained with Ponceau S and 
blocked with 1% (w/v) BSA in TTBS (100 mM Tris-HCl, pH 7.6, 0.9% (w/v) NaCl, 0.1% (v/v)  
Tween 20) for 30 min. Thereafter, the OTB mab was used as the primary antibody at a concentration 
of 10 µ g/mL (concentration was optimized in preliminary assays) and incubated for 1 hour at RT.  
Anti-mouse IgG-HRP (1:80,000, 45 min) and ECL were used for detection. Chemiluminescent signals 
were detected using a CCD camera system (Fuji LAS-1000).  
For  quantification,  ochratoxin-conjugates  in  varying  concentrations  were  applied  directly  on  a 
nitrocellulose membrane (via dot blotting), followed by immunodetection as described above. 
2.6. Establishment and Optimization of an Indirect Competitive OTB-ELISA  
The initial ELISA was performed using the same parameters as optimized for the use of the crude 
hybridoma supernatant (see Table 1) [22]. Briefly, 96 well-plates (MaxiSorp, Nunc, Germany) were 
coated overnight at 4 ° C with OTB-BSA conjugate (16 ng/well) in coating buffer (32 mM Na2CO3,  Toxins 2010, 2                             
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70 mM NaHCO3, pH 9.6). Plates were washed three times with washing buffer and two times with 
PBS (10 mM sodium phosphate, 150 mM NaCl, pH 7.4) followed by blocking in blocking solution for 
one hour at RT. Standards, controls or samples (50 µ L) were applied and 50 µL  OTB mab were added. 
After one hour incubation, plates were washed again and 100 µ L detection antibody (goat anti-mouse 
IgG (Fc-Fragment)-HRP, 1:5,000) were incubated for one hour. After washing, 50 µ L TMB solution 
were added to each well and incubated 15 min at RT protected from light. The reaction was stopped by 
addition of 50 µ L 2 M sulfuric acid and absorbance was recorded at 450 nm using an ELISA reader 
(Tecan, Infinite 200). 
For optimization of ELISA conditions, grid experiments, allowing for the combination of variations 
of the different parameters, were performed. Parameters included coating concentrations (8, 16, 32 and 
80 ng OTB-BSA per well), OTB mab concentrations (0.007, 0.02, 0.07, 0.2, 0.7 and 1 µ g OTB mab/mL), 
ionic strength (0.1× , 0.5× , 1×  and 1.5×  PBS), pH (7.0, 7.4 and 8.0), blocking proteins at different 
concentrations  (Casein  (0.5,  1,  2%),  BSA  (1,  2,  3%),  Ovalbumin  (0.1,  0.2, 0.5%) and  skim milk 
powder  (0.1,  0.2,  0.5%))  and  incubation  conditions  (static  at  37  ° C  vs.  shaking  at  RT).  Four 
concentrations of OTB and OTA (0.01, 0.1, 1, 10 µ M) were used for the latter experiments. 
Table 1. Comparison of ELISA conditions.  
ELISA Step  Before Optimization  After Optimization 
Plate coating with  
OTB-BSA conjugate 
16 ng/well 
coating buffer 
4 ° C, overnight 
16 ng/well 
coating buffer 
4 ° C, overnight 
Buffer 
PBS  (10  mM  sodium  phosphate, 
150 mM NaCl, pH 7.4) 
PBS (15 mM sodium phosphate, 
225 mM NaCl, pH 7.0) 
Washing buffer  PBS with 0.05% (v/v) Tween 20  PBS with 0.05% (v/v) Tween 20 
Blocking solution  1% (w/v) casein in PBS  1% (w/v) BSA in PBS 
Blocking  RT, 1 h, static  RT, 1 h, static 
Primary antibody  
(mouse anti-OTB IgG) 
300 ng IgG/mL blocking solution 
37 ° C, static 
70 ng IgG/mL blocking solution 
RT, shaking 
Detection antibody 
(goat anti-mouse IgG  
(Fc-fragment)-HRP) 
1:5,000 in blocking solution 
37 ° C, static 
1:5,000 in blocking solution 
RT, shaking 
2.7. Establishment of Competitive Binding Curves of OTB and OTA  
Complete competition curves for OTB and OTA were established using, OTA and OTB diluted in 
PBS (pH 7.0). Concentrations ranged from 10 nM to 6.6 µ M and 10 nM to 200 µ M for OTB and OTA, 
respectively. Relative cross-reactivity was determined using Equation 1. 
% cross-reactivity =  100
(OTA) ion  concentrat   inhibitory   50%
(OTB) ion  concentrat   inhibitory   50%
   (1) 
The limit of detection (LOD; reagent blank + 3×  SD of reagent blank) for OTB was 3 µ g/L (8 nM), 
whereas the limit of quantification (LOQ; reagent blank + 10×  SD of reagent blank) was 3.7 µ g/L  
(10 nM). The LOD for OTA was 129 µ g/L (320 nM), whereas the LOQ was 174 µ g/L (430 nM). 
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2.8. Preparation of Matrix Samples for ELISA  
In order to study matrix-associated effects, a very small basket study with beverages was carried 
out. Beverages randomly chosen in a local supermarket were coffee, beer (German wheat beer) and red 
wine (Merlot), known to often contain ochratoxins at low levels. Coffee was brewed using a standard 
filter coffee maker, whereas the beer and wine were used for analysis as taken from the supermarket. 
Sample preparation was adapted from the method by Wang and co-workers [24], who optimized 
sample preparation for the detection of OTA in beverages and foods via ELISA. Briefly, for wine and 
coffee, 6 mL of sample were mixed with 24 mL chloroform and vigorously shaken for 30 min at RT. 
Then, 16 mL PBS (pH 9.0) were added and mixed. For phase separation centrifugation (1,560 ×  g,  
5 min, RT) was applied and the supernatant (water-phase) was aliquoted into fresh tubes and stored at  
−20 ° C until further use.  
Beer was used without extraction, but was ultrasonically degassed for approximately 15 min and 
then stored at −20 ° C as small aliquots until further use.  
2.9. Detection of OTB in Spiked Diluted Matrix Samples via ELISA  
Matrix samples (see Section 2.8) were diluted with PBS (pH 7.0) using dilution factors of 2 to 25 for 
analysis until the absence of matrix-associated quenching effects was observed. Following establishment 
of optimal dilutions, diluted matrices were spiked with OTB ranging from 10 nM to 6.6 µ M. 
2.10. Calculations and Statistics  
Duplicate samples were analyzed in each ELISA plate and run simultaneously with controls for 
total binding (vehicle, i.e., PBS or diluted sample matrix) and blank (samples without anti-OTB mab). 
Data were processed first using MS EXCEL 2003. Sample absorbance values were blank-subtracted 
and  then  compared  to  total  binding  (=100%).  Means  of  the  duplicates  in  each  independently  run 
ELISA were used as value of one independent replicate. Means of at least three independent replicates 
were further processed with GraphPad Prism 4.03 using nonlinear regression (sigmoid dose-response 
with  variable  slope)  with  constraints  (0%  TOP  and  100%  BOTTOM)  and  anchorage  points.  In 
addition, the competitor concentration inhibiting 50% binding (IC50) was determined. The degree of 
competition was calculated using Equation 2. 
% OTB binding = (absorbanceOTB/ absorbancePBS) ×  100  (2)  
Spiked beverage samples were compared to OTB standards in PBS using a t-test with p < 0.05. 
3. Results 
3.1. Purification and Characterization of the OTB Antibody 
Antibody purification resulted in a highly purified OTB mab, which was tested via SDS-PAGE with 
subsequent  silver-staining  (Figure  2).  The  gels  confirmed  the  expected  distinct  banding  of 
immunoglobulin in the absence of any other protein banding. Under reducing conditions, two bands Toxins 2010, 2                             
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were visible at 53 ±  1 kDa and 31 ±  1 kDa, representing the heavy and light chains, respectively. 
Under non-reducing conditions, only one protein band at 168 ±  5 kDa was observed.  
Figure  2.  Representative  SDS-PAGE  results.  (A)  7.5%  non-reducing  gel;  (B)  12% 
reducing gel; P-, before purification; P+, after purification; Numbers refer to estimated 
molecular weights (kDa).  
 
3.2. Characterization of Ochratoxin-BSA Conjugates 
The  analysis  of  OTA-BSA  protein  concentration  confirmed  the  5  mg/mL  of  OTA-BSA  as 
proclaimed by Sigma-Aldrich, while a concentration of 1.3 ±  0.2 µ M OTA (n = 3, mean ±  SD) fell 
short of the expected value. For the in-house synthesized OTB-BSA conjugate, a protein concentration 
of  16.3  ±   1.7  µ g/mL  (n  =  3,  mean  ±   SD)  and  a  OTB  concentration  of  27.2  ±   1.2  µ M  (n  =  3,  
mean ±  SD) was established. Above ochratoxin-BSA protein concentrations were used for all ensuing 
calculations, e.g., dot-blots and western blots.  
Above values were also used to calculate the labeling ratios (Ochratoxin: BSA) of 5.3 and 0.36 for 
OTB-BSA  and  OTA-BSA,  respectively.  These  values  differed  from  those  determined  earlier  
(OTB-BSA, [22]) or provided by the supplier (OTA-BSA, Sigma-Aldrich), suggesting partial loss of 
ochratoxin-BSA binding during frozen storage. 
3.4. Detection and Quantification of Ochratoxin-BSA Conjugates via Western Blot Analyses 
Western blot analysis enabled the control of the ELISA components, thus confirming the previously 
described method [22]. In addition, Western blot analysis tested and confirmed the potential usability 
of  the  OTB  mab  for  the  analysis  of  OTB-protein  complexes.  Moreover,  Western  blot  analysis 
demonstrated  that  the  OTB  mab  is  capable  of  detecting  OTB-  and  OTA-protein  complexes  with 
similar specificity (Figure 3), albeit with different sensitivity (Figure 4).  
Whether  this  approach  is  applicable  to  the  detection  of  non-covalently  bound,  but  chemically 
matrix-linked OTB (e.g., in immunocytochemistry) will be established in future experiments. Toxins 2010, 2                             
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Figure 3. The specificity of OTB- and OTA-protein complex detection by Western blot 
analysis. A representative Western blot with 1 µ g of protein per lane; 10 µ g/mL OTB mab; 
30 seconds ECL detection. 
 
Figure 4. The sensitivity of OTB- and OTA-protein complex detection by Western blot 
analysis.  Representative  Dot  blot  results  after  60  seconds  ECL  detection,  10  µ g/mL  
OTB mab, 30 µ L sample/dot. 
 
3.5. Establishment and Optimization of an Indirect Competitive OTB-ELISA 
Based on the variant combinations of ELISA parameters used in the grid experiments, the most 
ideal ELISA conditions were identified (Table 1). The comparison of the conditions employed in the 
initial ELISA with those of the optimized ELISA demonstrated that not only a simpler but also more 
convenient (RT vs. 37 ° C incubation) ELISA was optimal. The most effective modification was the 
choice of protein for blocking. The use of BSA, rather than casein, ovalbumin or skim milk resulted in 
highest sensitivity towards OTB and lowest cross-reactivity towards OTA. This may due to the high 
affinity of OTA to BSA.  
These optimized conditions were used to investigate competitive effects of OTB and structurally 
related molecules e.g., OTA, coumarin and phenylalanine. No cross-reactivity to other structurally 
related molecules (coumarin and phenylalanine) was observed (data not shown), confirming earlier 
findings [22]. Detection could be achieved within a range of 0.01 to 10 µ M OTB (Figure 5). The OTB 
concentration causing 50% inhibition (IC50) was 0.15 µ M (95% CI: 0.12–0.19, n = 5), suggestive of a 
very sensitive assay. The limit of detection (LOD; reagent blank + 3×  SD of reagent blank) for OTB Toxins 2010, 2                             
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was 3 µ g/L (8 nM), whereas the limit of quantification (LOQ; reagent blank + 10×  SD of reagent 
blank) was 3.7 µ g/L (10 nM).  
OTA was detected  with  an  IC50 of 5.65 µ M (95% CI: 4.18-7.65, n = 6). Based on the IC50’s 
determined, the cross-reactivity of OTA with the OTB mab was calculated to be very low (2.7%). The 
LOD for OTA was 129 µ g/L (320 nM), whereas the LOQ was 174 µ g/L (430 nM). 
Figure  5. Competitive binding curves of OTB and OTA. Blue symbols, OTB (n = 5),  
red symbols, OTA (n = 6); Data are means ±  SEM. 
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3.6. Matrix Interference and Its Removal 
Reduction of matrix interference is frequently achieved in ELISA by simple dilution with assay 
buffer, especially when a highly sensitive assay is available. Samples containing high pigment, flavors, 
tannin  or  lipids  generally  interfere  with  the  color  development  in  ELISA.  Therefore,  chloroform 
extraction with subsequent alkaline buffer dilution, where the interfering substances are retained in the 
chloroform  layer  and  toxins  (in  this  case  ochratoxins)  are  easily  dissolved  in  alkaline  solution,  
was chosen.  
In a first set of analyses, prepared matrix samples were diluted with PBS pH 7.0 using dilution 
factors of 2 to 25 for analysis, i.e., until no quenching effects of the matrices were detectable. Based on 
the latter results, no quenching effects were detected (Figure 6) at dilutions of 1:2, 1:10 and 1:20 for 
coffee, beer and wine, respectively. 
3.7. Detection of OTB in Various Matrices 
Ten different concentrations of OTB were added (spiking experiment) to diluted matrix samples 
using the optimized dilutions of the respective sample (matrix) type (see above). The resulting spiked 
matrix samples were analyzed using the optimized OTB ELISA. The resulting competition curves 
were compared to that established with pure OTB in PBS (Figure 6). No significantly differences in 
the curves (form, slope, range) could be detected for all three matrices (coffee, beer, wine), when 
compared to the standard OTB curve. This t suggests that the optimized OTB ELISA provides for a 
robust and sensitive OTB detection in these matrices. Toxins 2010, 2                             
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Figure 6. Competitive binding curves of OTB in different matrices. Black symbols, pure 
OTB standards (n = 5), grey symbols, OTB spiked into matrices; (A) red wine (n = 3);  
(B) coffee (n = 4); (C) beer (n = 3); Data are means ±  SEM. 
 
4. Discussion 
Despite that the role of OTA in a human disease (BEN, Balkan Endemic Nephropathy) and in the 
observed increased incidence of human renal urothelial tumors is still under debate [16], the European 
Union (EU) has defined regulatory limits for OTA, i.e., 10 ppb in dried vine fruits and instant coffee,  
5 ppb in cereals and roasted coffee and 2 ppb in wine, whereas no limits were set for beer [19], in 
order to protect consumers from mycotoxin-related risks. Similarly, although the potential role of OTB 
in both, the human and the porcine nephropathy and the human urothelial tumors, has so far largely 
been ignored and remains to be elucidated, the toxicological database available to date would suggest 
that OTB should be considered as seriously as OTA as causative toxins in the observed increased 
A 
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incidence of human renal urothelial tumors. Moreover, OTB was demonstrated to be co-produced with 
OTA and is therefore frequently found in OTA-contaminated products [2,20,21]. Consequently, single 
or combined exposures to OTA and OTB could be causative for the observed human diseases and as 
such should be monitored routinely in order to protect the consumer. Although HPLC and LC-MS/MS 
are  established  technologies  available  for  most  product  testing  laboratories,  the  running  cost  and 
skilled personnel required can be prohibitive for routine high-throughput analyses of OTA and OTB in 
food and feed products including beverages e.g., beer, wine and liquors. Here we present an indirect 
competitive  OTB-ELISA  with  a  low  detection  limit  and  a  broad  quantification  range.  This  
OTB-ELISA could provide an alternative approach with high-throughput capacity. Indeed, using the 
limit levels set for OTA by the EU and assuming that similar limits would be applied to OTB, the LOQ 
of 3.7 ppb that was established for the indirect competitive OTB-ELISA would suffice for routine 
quantification of OTB contamination in dried vine fruits, instant coffee, cereals and roasted coffee. As 
the OTB mab shows very high sensitivity (pg range for OTB) and specificity for OTB-BSA, very low 
cross-reactivity to OTA-BSA, and no cross-reactivity to either coumarin or phenylalanine, specific 
identification of the contaminant (OTA or OTB) is possible.  
Due  to  the  high  specificity  of  the  OTB  mab,  as  demonstrated  in  Western  and  dot  blotting 
applications, this antibody could potentially find use in other applications, e.g., immunohistochemistry 
and immunocytochemistry, and thus help in elucidating the causality of OTB exposure and etiology or 
progression of Balkan Endemic Nephropathy and the observed increased incidence of human renal 
urothelial tumors. 
In summary, the described OTB mab is suitable for use in ELISA and Western analysis with high 
specificity  and  sensitivity  for  OTB.  Moreover,  the  indirect  competitive  OTB-ELISA,  which  was 
optimized in the present study, was shown to be a sensitive and specific tool to detect OTB in various 
matrix samples with only minor sample pretreatment which could be applied as a rapid and low cost 
high-throughput technology for future food sample analysis. 
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